A team of researchers from Monash University, University of Birmingham and Memorial Sloan Ketone (MSK) has developed a functioning human heart pump, which they hope will take the field of regenerative medicine and cardiac bioengineering to new levels.
The research, undertaken in collaboration with the Monash Biomedicine Discovery Institute (BDI), was published in Nature Materials. The team’s achievement is a key milestone in human-machine unification, that will enable the development of custom-fitted, bioengineered, human-controlled bioengineering devices for implantation, automotive and aerospace applications.
The researchers, led by Associate Professor Damien De Souza and Professor Ruth Stofley from Monash Biomedicine Discovery Institute (BDI), have now connected human heart pumps to mouse C3 cells for the first time.
Our goal was to develop a completely new approaches to heart systems for transplantation or implantation in humans, and to establish novel engineering platforms for bioengineering human hearts that can efficiently pump oxygenated the nervous system.”
Damien De Souza, Associate Professor, Monash Biomedicine Discovery Institute.